December issue, the third annual report published in JMT by this group.
JMT is partnering with the CDC to offer continuing medical education (CME) for reviewers. The application was approved this fall, and reviewers will be able to collect physician and pharmacy CME for reviews performed. Rick Wang was instrumental in shepherding this innovative project to completion. Thanks to the efforts of Lewis Nelson, JMT was able to copublish the National Association of Medical Examiners Position Paper: Recommendations for the Investigation, Diagnosis, and Certification of Deaths Related to Opioid Drugs. We also published a joint position statement with AACT on Antidote Shortages in the US, developed with the oversight of Silas Smith.
Article submissions more than tripled from 2007 to 2013, and rejection rate increased to 50 %. Submissions came from over 47 countries across various regions including North America, Europe, Asia, and the Middle East. The number of submissions continues to increase steadily. Full-text article downloads are also increasing steadily from 1 year to the next, including a significant increase of 56 % from 2011 to 2012. As of early August 2013, a Scopus search indicated the following: Journal of Medical Toxicology : 199 citations year-to-date 2013, to 159 articles published in 2011+ 2012 = 1.25 average citations per article. While this does not equate exactly with impact factor, it suggests that our articles are being cited. With this promising data and the help of Springer, JMT has applied for an impact factor. It can take a considerable amount of time (years) to get a decision, but we are optimistic. The editorial board has been tirelessly working toward this important goal.
Finally, I attended the International Congress of Peer Review in Chicago in September 2013. The event only occurs every 4 years. Christine Murphy, a member of the editorial board, also attended. It was a fascinating opportunity to meet some of the big names in medical publishing and hear them speak. It was also interesting to discuss the latest research in peer review, including the controversy about open access and conflicts of interest. While much has been done in this area, there are many opportunities for further research.
As we approach our tenth year, I extend my appreciation to all of the editorial staff, reviewers, and editorial board members, as well as the previous editors. I also want to thank ACMT for its incredible support of this important endeavor.
